alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    The Registrants Quarterly Report on Form 10-Q for the period ended June 30, 2009 (the
Periodic Report), fully complies with the requirements of Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934, as amended; and2.
    
    The information contained in the Periodic Report fairly presents, in all material respects, the
financial condition and results of operations of the Registrant.
   /s/ Richard J. LampenRichard J. LampenChief Executive Officer
(Principal Executive Officer)
 /s/ Alfred J. SmallAlfred J. SmallChief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
Order entered August 27, 2014

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00920-CV

RODRICK SAMPLES, Appellant

V.

THE DALLAS COUNTY SPECIAL CIVIL SERVICE COMMISSION, ET AL., Appellees

On Appeal from the 160th Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC12-11245

ORDER

Before Chief Justice Wright and Justices Lang-Miers and Brown

We GRANT appellant’s August 6, 2014 motion to change his appeal from a direct 

appeal to restricted appeal. This appeal will proceed as a restricted appeal.

/s/ ADA BROWN 

JUSTICE
**EXHIBIT
      32.2**





SECTION
      906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER OF CANAM URANIUM
      CORP.





In
      connection with the accompanying Quarterly Report on Form 10-QSB of Canam
      Uranium Corp., for the quarter ended January 31, 2007, the undersigned, Ryan
      Gibson, Chief Executive Officer of Canam Uranium Corp., does hereby certify
      pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that:





(1)
      such
      Quarterly Report on Form 10-QSB for the quarter ended January 31, 2007 fully
      complies with the requirements of Section 13(a) or 15(d) of the Securities
      Exchange Act of 1934, as amended; and





(2)
      the
      information contained in such Quarterly Report on Form 10-QSB for the quarter
      ended January 31, 2007 fairly presents, in all material respects, the financial
      condition and results of operations of Canam Uranium Corp.




Date:
              March 16, 2007
            
            /s/
              Ryan
              GibsonRyan
              GibsonPresident
              and
              Chief Executive Officer
.

. **OFFICE** OF **THE ATTORNEY**  **GENERAL OF**  TEXAS **AUSTIN**

Eon. Prmlk R. Hurry OOUnty Attorney Panhandle,Texar Dear Mr. Murray;

- whether or not t to oonrtftutional

lb4 warrant8 againstroad de tax to 

## oset tfme or oat they ret tax authorized
**ha8 boon**  modted adopted In 1890 thorleean mlditfonal .OO ot raluatlonror roada. If toted by a ng eleotorr of the e held for that purpose,


# Y&f entlaal quo&ion was pXvmmted to thlr dopart- 

# ‘mnt by t& rable Joe B. S&t&, Countr Auditor of Hunt adl the EonorablbSoott Qaine@, krrtrtantAttornq Ceumral, County rrnderodan opinion on thir queetionMaroh llth, 193i?, a oopy of raid opinionbefog **4n41064d** herrwith.

.

### :

, _. Eon. hnk R. Muira7

. ' January l&h, 1939 pw ia

In+@ 'toyour inquiry, ln tier of the foregoing authoritl.8,it is the opinion of this departmoatthat where lag &litional road malntenams tax has been authorimd to be letied and oolleotedat an eleotlon oalled for that purpose **br** the ajorltr or the qyallfiedvoters of the oountr, the Cemissioners* Court ~7 fix a greatejr or less rate of 1~7 each JWU, **not to**  l xoeed 134 on tie #lOO.OOvmrth oi taxable **property.** Trusting thit the roreeoing +wwers **your** inquir7, I am Yours very truly ATTORNlIYGENERALWTl3XAS By (Signed)ARDELL WILLIAMS **Assistant**

**.** - AW:OB APPROVED: (Slgn,d)GRRALD 0. MARN Am- GENERU OF TEXAS
Exhibit 32.2

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(18 U.S.C. 1350)

Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), the undersigned officer of BioDelivery Sciences International, Inc., a Delaware corporation (the Company), does hereby certify, to the best of such officers
knowledge and belief, that:

(1) The Annual Report on Form 10-K for the year ended December 31, 2008 (the Form 10-K) of the
Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The
information contained in the Form 10-K fairly presents, in all materials respects, the financial condition and results of operations of the Company.



|                     |  |  |  |                                                                   
|-------------------- |  |  |  | ------------------------------------------------------------------
|                     |  |  |  | /s/ James A. McNulty                                              
|Date: March 20, 2009 |  |  |  | James A. McNulty, Secretary, Treasurer and Chief Financial Officer

This certification shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Securities Exchange Act.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          JUL-31-2000             JUL-31-1999
<PERIOD-START>                             AUG-01-1999             AUG-01-1998
<PERIOD-END>                               JUL-31-2000             JUL-31-1999
<CASH>                                         231,271                  82,383
<SECURITIES>                                         0                       0
<RECEIVABLES>                                1,815,182                  21,052
<ALLOWANCES>                                         0                       0
<INVENTORY>                                     10,340                  14,810
<CURRENT-ASSETS>                             2,056,793                 118,245
<PP&E>                                       3,781,674<F1>           1,671,162<F2>
<DEPRECIATION>                               (408,624)               (166,275)
<TOTAL-ASSETS>                               5,429,843               1,623,132
<CURRENT-LIABILITIES>                        2,604,640                 909,217
<BONDS>                                      2,210,012                 751,976
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                        23,482                  17,785
<OTHER-SE>                                     591,709                (55,846)
<TOTAL-LIABILITY-AND-EQUITY>                 5,429,843               1,623,132
<SALES>                                      1,856,026                 706,886
<TOTAL-REVENUES>                             1,856,026                 706,886
<CGS>                                      (1,081,468)               (413,015)
<TOTAL-COSTS>                              (1,081,468)               (413,015)
<OTHER-EXPENSES>                           (1,988,649)             (1,151,900)
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                           (105,729)                (41,014)
<INCOME-PRETAX>                                      0                       0
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (1,319,820)               (897,043)
<EPS-BASIC>                                     (0.07)<F3>              (0.05)
<EPS-DILUTED>                                   (0.07)<F4>              (0.05)
<FN>
<F1>Includes intangible assets
<F2>Includes intangible assets
<F3>Net loss attributable to Common Stockholders includes fair value of warrants
issued
<F4>Net loss attributable to Common Stockholders includes fair value of warrants
issued
</FN>


</TABLE>
#### STATE of Missouri, Plaintiff/Respondent, v. Barry MURPHY, Defendant/Appellant. Barry Carlton Murphy BAY, Movant/Appellant, v. STATE of Missouri, Respondent/Respondent.

Nos. 65000, 66992.

Missouri Court of Appeals, Eastern District, Division Four.

Sept. 26, 1995.

*416Elizabeth R. Haines, St. Louis, for appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., David J. Hanson, Asst. Atty. Gen., Jefferson City, for respondent.

Before AHRENS, P. J., and PUDLOWSKI and GRIMM, JJ.

PER CURIAM.

In this jury-tried case, defendant was convicted of distributing a controlled substance within 1000 feet of a school in violation of § 195.214, RSMo 1994. The trial court sentenced him as a prior and persistent offender to fifteen years. Thereafter, defendant filed a Rule 29.15 motion which was denied without an evidentiary hearing. He appeals.

No jurisprudential purpose would be served by a written opinion. However, the parties have been furnished with a memorandum opinion for their information only, setting forth the facts and reasons for this order.

The judgments are affirmed in accordance with Rules 30.25(b) and 84.16(b).
1The Honorable Carol E. Jackson, United States District Judge for the Eastern

District of Missouri.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 00-2371

___________

Deborah Markham; Michael Rossini, *

*

Appellants, *

* Appeal from the United States

v. * District Court for the

* Eastern District of Missouri.

Maryland Heights Police Department; *

Neil Kurlander; Mike Kloss; Steve *

Osterloh, *

*

Appellees. *

___________

 Submitted: August 2, 2000 

 Filed: August 31, 2000

___________

Before RICHARD S. ARNOLD, HANSEN, and BYE, Circuit Judges. 

___________

PER CURIAM.

Deborah Markham and Michael Rossini appeal the district court’s1 denial of

their Federal Rule of Civil Procedure 60(b) motion. We conclude that the court did not

abuse its discretion in denying their motion, because it was untimely--alleging an error

that could have been presented in a timely appeal, but having been filed more than
-2-

thirty days after entry of judgment--and because it failed to present new arguments.

See Sanders v. Clemco Indus., 862 F.2d 161, 169 (8th Cir. 1988).

Accordingly, we affirm the judgment of the district court. See 8th Cir. R.

47A(a).

A true copy.

Attest:

CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
[Federal Register Volume 61, Number 84 (Tuesday, April 30, 1996)]
[Notices]
[Page 19079]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10591]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


John E. Fogarty International Center for Advanced Study in the 
Health Sciences; Notice of Meeting of the Fogarty International Center 
Advisory Board

    Pursuant to Public Law 92-463, as amended, notice is hereby given 
of the thirty-third meeting of the Fogarty International Center (FIC) 
Advisory Board, May 21, 1996, in the Lawton Chiles International House 
(Building 16), at the National Institutes of Health.
    The meeting will be open to the public from 8:30 a.m. to 12:15 p.m.
    The agenda will begin with a report by the Director, FIC. 
Presentations will include reports on the NIH AIDS research programs 
evaluation and the international aspects of the Office of AIDS Research 
review. FIC follow-up and plans for the FIC AIDS International Training 
Program in response to these reviews also will be presented. An update 
on the status of the implementation of the FIC long-range plan will 
focus on emerging and re-emerging infectious diseases, a forthcoming 
colloquium on ebola virus research and a workshop on malaria research 
in Africa. There also will be a report on global vaccine development.
    In accordance with the provisions of sections 552b(c)(4) and 
552b(c)(6), Title 5, United States Code and section 10(d) of Public Law 
92-463, as amended, the meeting will be closed to the public from 1:30 
p.m. to adjournment for the review of applications for awards under the 
Senior International Fellowship Program and the International Research 
Fellowship Program; and the Fogarty International Research 
Collaboration Awards and HIV, AIDS and Related Illnesses Collaboration 
Awards.
    Paula Cohen, Committee Management Office, Fogarty International 
Center, National Institutes of Health, Building 31, Room B2C08, 31 
CENTER DR MSC 2220, Bethesda, Maryland 20892-2220, telephone: 301-496-
1491, will provide a summary of the meeting and a roster of the 
committee members upon request.
    Irene Edwards, Executive Secretary, Fogarty International Center 
Advisory Board, Building 31, Room B2C08, telephone: 301-496-1491, will 
provide substantive program information.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
contact Ms. Cohen at least 2 weeks in advance of the meeting.

(Catalog of Federal Domestic Assistance Program No. 93.989, Senior 
International Awards Program.)

    Dated: April 23, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-10591 Filed 4-29-96; 8:45 am]
BILLING CODE 4140-01-M
**Exhibit
      31.1**




**CERTIFICATION**




I,
      Michael D. Queen, certify that:




1.  I
      have
      reviewed this Quarterly Report on Form 10-Q of Universal Capital Management,
      Inc.;




2.  Based
      on
      my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;




3.  Based
      on
      my knowledge, the financial statements, and other financial information included
      in this report, fairly present in all material respects the financial condition,
      results of operations and cash flows of the registrant as of, and for, the
      periods presented in this report;




4.  The
      registrant’s other certifying officer and I are responsible for establishing and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules
      13a-15 (e) and 15d-15 (e)) for the registrant and have:




(a)  Designed
      such disclosure controls and procedures, or caused such disclosure controls
      and
      procedures to be designed under our supervision, to ensure that material
      information relating to the registrant, including its consolidated subsidiaries,
      is made known to us by others within those entities, particularly during the
      period in which this report is being prepared;




(b)  Evaluated
      the effectiveness of the registrant’s disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this
      report based on such evaluation; and




(c)  Disclosed
      in this report any change in the registrant’s internal control over financial
      reporting that occurred during the registrant’s most recent fiscal quarter that
      has materially affected, or is reasonably likely to materially affect, the
      registrant’s internal control over financial reporting; and




5.  The
      registrant’s other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      registrant’s auditors and the audit committee of the registrant’s board of
      directors:




(a)  All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant’s ability to record, process, summarize and
      report financial information; and




(b)  Any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the registrant’s internal control over financial
      reporting.




Date: December
              13, 2006
            
            /s/
              Michael D. QueenMichael
              D. QueenPrincipal
              Executive Officer
EXHIBIT 10.24

          Summary of Principal Terms of Employment of Patrick E. Phelan



Effective  November  7, 2005,  the Company  hired  Patrick E. Phelan to serve as
Executive Vice President and Chief  Financial  Officer of North Bay Bancorp (the
"Company").  Mr. Phelan  received a signing  bonus of $10,000.  The initial base
salary for Mr.  Phelan is  $175,000  per year.  The  Company  also  granted  him
incentive stock options for 5,000 shares of the Company's common stock.

Mr. Phelan also participates in the following benefits:

     o    Group  medical  and dental  insurance  effective  the first day of the
          month following date of hire;

     o    Group term life insurance and group  disability  insurance,  effective
          the first day of the month following date of hire;

     o    Participation in the Bank's profit sharing and 401(k) plans, for which
          you will be  eligible  the first of the  month  following  90-days  of
          employment;

     o    Paid  Catastrophic  leave  (CAT)  in  accordance  with  the  Company's
          policies as described in the Employee Handbook;

     o    Five weeks Paid Time Off (PTO) per year,  accrued on a pro-rata  basis
          beginning the first day of the month following date of hire;

     o    Flexible  benefits plan (or "cafeteria  plan") effective the first day
          of the month following date of hire.
[Federal Register Volume 61, Number 83 (Monday, April 29, 1996)]
[Notices]
[Pages 18722-18723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10492]



=======================================================================
-----------------------------------------------------------------------

COMMITTEE FOR THE IMPLEMENTATION OF TEXTILE AGREEMENTS


Cancellation of a Limit on Certain Wool Textile Products Produced 
or Manufactured in India

April 23, 1996.
AGENCY: Committee for the Implementation of Textile Agreements (CITA).

ACTION: Issuing a directive to the Commissioner of Customs cancelling a 
limit.

-----------------------------------------------------------------------

EFFECTIVE DATE: April 24, 1996.

FOR FURTHER INFORMATION CONTACT: Jennifer Aldrich, International Trade 
Specialist, Office of Textiles and Apparel, U.S. Department of 
Commerce, (202) 482-4212.

SUPPLEMENTARY INFORMATION:

    Authority: Executive Order 11651 of March 3, 1972, as amended; 
section 204 of the Agricultural Act of 1956, as amended (7 U.S.C. 
1854); Uruguay Round Agreements Act.

    The United States Government has decided to rescind the restraint 
on imports of women's and girls' wool coats in Category 435 from India 
established on April 18, 1996, pursuant to Article 6.10 of the Uruguay 
Round Agreement on Textiles and Clothing (ATC).
    In the letter published below, the Chairman of CITA directs the 
Commissioner of Customs to cancel the limit established for Category 
435 for the period April 18, 1996 through April 17, 1997.
    A description of the textile and apparel categories in terms of HTS 
numbers is available in the CORRELATION: Textile and Apparel Categories 
with the Harmonized Tariff Schedule of the United States (see Federal 
Register notice 60 FR 65299, published on December 20, 1995). Also see 
61 FR 16760, published on April 17, 1996.
D. Michael Hutchinson,
Acting Chairman, Committee for the Implementation of Textile 
Agreements.

Committee for the Implementation of Textile Agreements
April 23, 1996.

Commissioner of Customs,
Department of the Treasury, Washington, DC 20229.

    Dear Commissioner: This directive amends, but does not cancel, 
the directive issued to you on April 11, 1996, by the Chairman, 
Committee for the Implementation of Textile Agreements. That 
directive concerns imports of certain wool textile products, 
produced or manufactured in India and exported during the period 
which began

[[Page 18723]]

on April 18, 1996 and extends through April 17, 1997.
    Effective on April 24, 1996, you are directed to cancel the 
limit established for Category 435 for the period April 18, 1996 
through April 17, 1997.
    The Committee for the Implementation of Textile Agreements has 
determined that this action falls within the foreign affairs 
exception to the rulemaking provisions of 5 U.S.C.553(a)(1).
Sincerely,
D. Michael Hutchinson,
Acting Chairman, Committee for the Implementation of Textile 
Agreements.
[FR Doc.96-10492 Filed 4-26-96; 8:45 am]
BILLING CODE 3510-DR-F